Crinetics Pharmaceuticals · 1 day ago
Regulatory Affairs Manager
Crinetics Pharmaceuticals is a pharmaceutical company based in San Diego, California, developing therapies for endocrine diseases. The Manager, Regulatory Affairs will support regulatory strategy implementation and work closely with the Executive Director to prepare regulatory submissions and develop global regulatory strategies.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Actively participate as a member of Regulatory Affairs teams and on cross-functional product development teams as needed
Act as a regulatory lead on a Phase 1, 2 or 3 clinical study
Contribute to developing and implementing regulatory strategies for global submissions from early research and development (R&D) through commercialization
Support the compilation, review and/or filing of INDs, CTAs, briefing documents and maintenance of development and approved applications
Coordinate and contribute to the authoring of submission documents such as DSURs, annual reports, routine submissions, and amendments as needed
Develop and manage project timelines for regulatory submissions
Maintain effective interactions with all contributors and Regulatory Affairs management, to ensure timely delivery of documents for regulatory submissions
Provide regulatory assistance and review of clinical study documentation, including review of clinical protocols, informed consent documents, clinical study recruitment materials, and essential document packages
Track submissions, correspondence, and commitments with health authorities
Provide guidance to project teams to ensure regulatory documentation is complete, accurate, of high quality and electronically functional
Write and/or maintain standard operating procedures, department working practices, templates and style guides, as appropriate
Conduct regulatory intelligence or research projects as required
Qualification
Required
Bachelor's or M.S./Ph.D. degree in scientific area
Minimum of 7 years' experience with a Bachelor's or 5 years' experience with M.S./Ph.D. of relevant Regulatory Affairs experience in a biotech/pharmaceutical setting
Minimum of 2 years supervisory experience
Equivalent combination of relevant education and applicable job experience may be considered
Experience and understanding of International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Good Clinical Practice (GCP) requirements, and FDA regulations
Experience and knowledge in the preparation of regulatory submissions, i.e. US IND and/or NDA sequences
Ability to work both independently with direction and within project teams and see all projects through to their completion
Excellent written and oral communication skills
Strong organizational skills, including the ability to prioritize workload
Strong interpersonal skills and the ability to deal effectively with other people/departments
Ability to meet deadlines and perform multiple tasks in a fast-paced setting
Software Knowledge: Windows, MS Office (Outlook, Word, Excel, PowerPoint). Knowledge of other software required: Advanced MS Word and Adobe PDF knowledge required
Preferred
Additional experience with Clinical Trial Authorizations (CTA) and Marketing Authorization Application (MAA) helpful
Experience interpreting and applying local regulations and guidance for drug development from early R&D through commercialization
Software Knowledge: Electronic document management systems use (e.g., Veeva) highly desired
Publishing experience and/or eCTD knowledge is desired (Lorenz, GlobalSubmit, eCTDExpress, etc)
Benefits
Discretionary annual target bonus
Stock options
ESPP
401k match
Top-notch health insurance plans for employees (and their families) to include medical, dental, vision and basic life insurance
20 days of PTO
10 paid holidays
Winter company shutdown
Company
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.65BKey Investors
Frazier Healthcare PartnersNational Institutes of HealthPerceptive Advisors
2024-10-08Post Ipo Equity· $500M
2024-02-28Post Ipo Equity· $350M
2023-09-12Post Ipo Equity· $350M
Recent News
2026-01-07
2026-01-07
Company data provided by crunchbase